Michael E. Meyers
Vice Chairman, Head of M&A, Credit & Royalty Finance, H.C. Wainwright & Co., LLC
Michael E. Meyers is listed as Vice Chairman, Head of M&A, Credit & Royalty Finance, H.C. Wainwright & Co., LLC. Michael is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.
Compiled from published conference agendas; not yet confirmed by Michael. Is this you? Claim this profile.
About
Michael Meyers has over 25 years of investment banking, venture capital, investment management and operating experience in healthcare, with an emphasis on the life sciences. Over the course of his career, Mr. Meyers has advised on ~ $250 billion in transaction value. H.C. Wainwright & Co., LLC is an employee-owned corporate and institutional investment bank with an emphasis on the life sciences. We underwrite, place, arrange, structure and advise small, mid and large capitalization companies spanning corporate finance (equity, equity-linked, credit and royalties), M&A and licensing advisory. In 2024, we completed 305 transactions in support of our clients. HCW maintains one of the largest fundamental equity research teams, with 20 senior publishing analysts covering ~ 500 publicly traded life sciences companies. In addition, HCW serves our clients across capital markets, placements, corporate access, investment and thematic conferences, and sales and trading.
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
Announced as a speaker.